Selection and characterization of FcεRI phospho-ITAM specific antibodies

Post-translational modifications, such as the phosphorylation of tyrosines, are often the initiation step for intracellular signaling cascades. Pan-reactive antibodies against modified amino acids (e.g., anti-phosphotyrosine), which are often used to assay these changes, require isolation of the spe...

Full description

Bibliographic Details
Main Authors: Nileena Velappan, Avanika Mahajan, Leslie Naranjo, Priyanka Velappan, Nasim Andrews, Nicholas Tiee, Subhendu Chakraborti, Colin Hemez, Tiziano Gaiotto, Bridget Wilson, Andrew Bradbury
Format: Article
Language:English
Published: Taylor & Francis Group 2019-10-01
Series:mAbs
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/19420862.2019.1632113
_version_ 1828150257508155392
author Nileena Velappan
Avanika Mahajan
Leslie Naranjo
Priyanka Velappan
Nasim Andrews
Nicholas Tiee
Subhendu Chakraborti
Colin Hemez
Tiziano Gaiotto
Bridget Wilson
Andrew Bradbury
author_facet Nileena Velappan
Avanika Mahajan
Leslie Naranjo
Priyanka Velappan
Nasim Andrews
Nicholas Tiee
Subhendu Chakraborti
Colin Hemez
Tiziano Gaiotto
Bridget Wilson
Andrew Bradbury
author_sort Nileena Velappan
collection DOAJ
description Post-translational modifications, such as the phosphorylation of tyrosines, are often the initiation step for intracellular signaling cascades. Pan-reactive antibodies against modified amino acids (e.g., anti-phosphotyrosine), which are often used to assay these changes, require isolation of the specific protein prior to analysis and do not identify the specific residue that has been modified (in the case that multiple amino acids have been modified). Phosphorylation state-specific antibodies (PSSAs) developed to recognize post-translational modifications within a specific amino acid sequence can be used to study the timeline of modifications during a signal cascade. We used the FcεRI receptor as a model system to develop and characterize high-affinity PSSAs using phage and yeast display technologies. We selected three β-subunit antibodies that recognized: 1) phosphorylation of tyrosines Y218 or Y224; 2) phosphorylation of the Y228 tyrosine; and 3) phosphorylation of all three tyrosines. We used these antibodies to study the receptor activation timeline of FcεR1 in rat basophilic leukemia cells (RBL-2H3) upon stimulation with DNP24-BSA. We also selected an antibody recognizing the N-terminal phosphorylation site of the γ-subunit (Y65) of the receptor and applied this antibody to evaluate receptor activation. Recognition patterns of these antibodies show different timelines for phosphorylation of tyrosines in both β and γ subunits. Our methodology provides a strategy to select antibodies specific to post-translational modifications and provides new reagents to study mast cell activation by the high-affinity IgE receptor, FcεRI.
first_indexed 2024-04-11T21:41:46Z
format Article
id doaj.art-10edd85e6c9b4e6fb382d9d01fc06caf
institution Directory Open Access Journal
issn 1942-0862
1942-0870
language English
last_indexed 2024-04-11T21:41:46Z
publishDate 2019-10-01
publisher Taylor & Francis Group
record_format Article
series mAbs
spelling doaj.art-10edd85e6c9b4e6fb382d9d01fc06caf2022-12-22T04:01:33ZengTaylor & Francis GroupmAbs1942-08621942-08702019-10-011171206121810.1080/19420862.2019.1632113Selection and characterization of FcεRI phospho-ITAM specific antibodiesNileena Velappan0Avanika Mahajan1Leslie Naranjo2Priyanka Velappan3Nasim Andrews4Nicholas Tiee5Subhendu Chakraborti6Colin Hemez7Tiziano Gaiotto8Bridget Wilson9Andrew Bradbury10Biosecurity and Public Health, Bioscience Division, Los Alamos National Laboratory, Los Alamos, NM, USADepartment of Pathology, University of New Mexico School of Medicine, Albuquerque, NM, USASpecifica Inc., Los Alamos, NM, USABiosecurity and Public Health, Bioscience Division, Los Alamos National Laboratory, Los Alamos, NM, USABiosecurity and Public Health, Bioscience Division, Los Alamos National Laboratory, Los Alamos, NM, USABiosecurity and Public Health, Bioscience Division, Los Alamos National Laboratory, Los Alamos, NM, USABiosecurity and Public Health, Bioscience Division, Los Alamos National Laboratory, Los Alamos, NM, USABiosecurity and Public Health, Bioscience Division, Los Alamos National Laboratory, Los Alamos, NM, USABiosecurity and Public Health, Bioscience Division, Los Alamos National Laboratory, Los Alamos, NM, USADepartment of Pathology, University of New Mexico School of Medicine, Albuquerque, NM, USASpecifica Inc., Los Alamos, NM, USAPost-translational modifications, such as the phosphorylation of tyrosines, are often the initiation step for intracellular signaling cascades. Pan-reactive antibodies against modified amino acids (e.g., anti-phosphotyrosine), which are often used to assay these changes, require isolation of the specific protein prior to analysis and do not identify the specific residue that has been modified (in the case that multiple amino acids have been modified). Phosphorylation state-specific antibodies (PSSAs) developed to recognize post-translational modifications within a specific amino acid sequence can be used to study the timeline of modifications during a signal cascade. We used the FcεRI receptor as a model system to develop and characterize high-affinity PSSAs using phage and yeast display technologies. We selected three β-subunit antibodies that recognized: 1) phosphorylation of tyrosines Y218 or Y224; 2) phosphorylation of the Y228 tyrosine; and 3) phosphorylation of all three tyrosines. We used these antibodies to study the receptor activation timeline of FcεR1 in rat basophilic leukemia cells (RBL-2H3) upon stimulation with DNP24-BSA. We also selected an antibody recognizing the N-terminal phosphorylation site of the γ-subunit (Y65) of the receptor and applied this antibody to evaluate receptor activation. Recognition patterns of these antibodies show different timelines for phosphorylation of tyrosines in both β and γ subunits. Our methodology provides a strategy to select antibodies specific to post-translational modifications and provides new reagents to study mast cell activation by the high-affinity IgE receptor, FcεRI.https://www.tandfonline.com/doi/10.1080/19420862.2019.1632113Phosphorylation state-specific antibodiesphage displayyeast displayFcεR1 receptor subunitspost-translational modifications
spellingShingle Nileena Velappan
Avanika Mahajan
Leslie Naranjo
Priyanka Velappan
Nasim Andrews
Nicholas Tiee
Subhendu Chakraborti
Colin Hemez
Tiziano Gaiotto
Bridget Wilson
Andrew Bradbury
Selection and characterization of FcεRI phospho-ITAM specific antibodies
mAbs
Phosphorylation state-specific antibodies
phage display
yeast display
FcεR1 receptor subunits
post-translational modifications
title Selection and characterization of FcεRI phospho-ITAM specific antibodies
title_full Selection and characterization of FcεRI phospho-ITAM specific antibodies
title_fullStr Selection and characterization of FcεRI phospho-ITAM specific antibodies
title_full_unstemmed Selection and characterization of FcεRI phospho-ITAM specific antibodies
title_short Selection and characterization of FcεRI phospho-ITAM specific antibodies
title_sort selection and characterization of fcεri phospho itam specific antibodies
topic Phosphorylation state-specific antibodies
phage display
yeast display
FcεR1 receptor subunits
post-translational modifications
url https://www.tandfonline.com/doi/10.1080/19420862.2019.1632113
work_keys_str_mv AT nileenavelappan selectionandcharacterizationoffceriphosphoitamspecificantibodies
AT avanikamahajan selectionandcharacterizationoffceriphosphoitamspecificantibodies
AT leslienaranjo selectionandcharacterizationoffceriphosphoitamspecificantibodies
AT priyankavelappan selectionandcharacterizationoffceriphosphoitamspecificantibodies
AT nasimandrews selectionandcharacterizationoffceriphosphoitamspecificantibodies
AT nicholastiee selectionandcharacterizationoffceriphosphoitamspecificantibodies
AT subhenduchakraborti selectionandcharacterizationoffceriphosphoitamspecificantibodies
AT colinhemez selectionandcharacterizationoffceriphosphoitamspecificantibodies
AT tizianogaiotto selectionandcharacterizationoffceriphosphoitamspecificantibodies
AT bridgetwilson selectionandcharacterizationoffceriphosphoitamspecificantibodies
AT andrewbradbury selectionandcharacterizationoffceriphosphoitamspecificantibodies